$2.06T
Total marketcap
$89.26B
Total volume
BTC 48.86%     ETH 17.27%
Dominance

Johnson & Johnson JNJ Stock

160.45 USD {{ price }} 1.115455% {{change_pct}}%
Exchange
NYSE
Market Cap
386.49B USD
LOW - HIGH [24H]
157.77 - 160.74 USD
VOLUME [24H]
7.89M USD
{{ volume }}
P/E Ratio
30.50
Earnings per share
5.26 USD

Johnson & Johnson Price Chart

Johnson & Johnson JNJ Financial and Trading Overview

Johnson & Johnson stock price 160.45 USD
Previous Close 156.87 USD
Open 155.49 USD
Bid 155 USD x 800
Ask 155.2 USD x 800
Day's Range 153.76 - 156.69 USD
52 Week Range 144.95 - 180.93 USD
Volume 21.73M USD
Avg. Volume 6.97M USD
Market Cap 373.51B USD
Beta (5Y Monthly) 0.573
PE Ratio (TTM) 29.05618
EPS (TTM) 5.26 USD
Forward Dividend & Yield 4.76 (3.07%)
Ex-Dividend Date November 20, 2023
1y Target Est 160.64 USD

JNJ Valuation Measures

Enterprise Value 381.18B USD
Trailing P/E 29.05618
Forward P/E 15.848825
PEG Ratio (5 yr expected) 3.62
Price/Sales (ttm) 3.7860198
Price/Book (mrq) 5.2436633
Enterprise Value/Revenue 3.864
Enterprise Value/EBITDA 10.887

Trading Information

Johnson & Johnson Stock Price History

Beta (5Y Monthly) 0.573
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 180.93 USD
52 Week Low 144.95 USD
50-Day Moving Average 152.72 USD
200-Day Moving Average 159.39 USD

JNJ Share Statistics

Avg. Volume (3 month) 6.97M USD
Avg. Daily Volume (10-Days) 8.88M USD
Shares Outstanding 2.41B
Float 2.4B
Short Ratio 2.35
% Held by Insiders 0.093%
% Held by Institutions 71.12%
Shares Short 15M
Short % of Float 0.61%
Short % of Shares Outstanding 0.61%

Dividends & Splits

Trailing Annual Dividend Rate 4.64
Trailing Annual Dividend Yield 2.95%
5 Year Average Dividend Yield 265.00%
Payout Ratio 0.8705
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends January 1, 2023
Most Recent Quarter (mrq) October 1, 2023
Next Fiscal Year End January 1, 2024

Profitability

Profit Margin 35.09%
Operating Margin (ttm) 30.07%
Gross Margin 67.55%
EBITDA Margin 35.49%

Management Effectiveness

Return on Assets (ttm) 10.11%
Return on Equity (ttm) 19.18%

Income Statement

Revenue (ttm) 98.66B USD
Revenue Per Share (ttm) 38.16 USD
Quarterly Revenue Growth (yoy) 6.80%
Gross Profit (ttm) 63.95B USD
EBITDA 35.01B USD
Net Income Avi to Common (ttm) 13.99B USD
Diluted EPS (ttm) 5.34
Quarterly Earnings Growth (yoy) 483.80%

Balance Sheet

Total Cash (mrq) 23.51B USD
Total Cash Per Share (mrq) 9.77 USD
Total Debt (mrq) 29.92B USD
Total Debt/Equity (mrq) 42.01 USD
Current Ratio (mrq) 1.21
Book Value Per Share (mrq) 29.59

Cash Flow Statement

Operating Cash Flow (ttm) 20.28B USD
Levered Free Cash Flow (ttm) 21.17B USD

Profile of Johnson & Johnson

Country United States
State NJ
City New Brunswick
Address One Johnson & Johnson Plaza
ZIP 08933
Phone 732 524 0400
Website https://www.jnj.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 152700

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Q&A For Johnson & Johnson Stock

What is a current JNJ stock price?

Johnson & Johnson JNJ stock price today per share is 160.45 USD.

How to purchase Johnson & Johnson stock?

You can buy JNJ shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Johnson & Johnson?

The stock symbol or ticker of Johnson & Johnson is JNJ.

Which industry does the Johnson & Johnson company belong to?

The Johnson & Johnson industry is Drug Manufacturers-General.

How many shares does Johnson & Johnson have in circulation?

The max supply of Johnson & Johnson shares is 2.41B.

What is Johnson & Johnson Price to Earnings Ratio (PE Ratio)?

Johnson & Johnson PE Ratio is 30.50380000 now.

What was Johnson & Johnson earnings per share over the trailing 12 months (TTM)?

Johnson & Johnson EPS is 5.26 USD over the trailing 12 months.

Which sector does the Johnson & Johnson company belong to?

The Johnson & Johnson sector is Healthcare.

Johnson & Johnson JNJ included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
S&P 500 INDEX SPX 5087.03 USD
+2.11
2.58B USD 2.58B USD
S&P 500 (Yahoo.com) GSPC 5087.03 USD
+2.11
2.58B USD 5038.83 USD 5094.39 USD 2.58B USD
S&P 100 SP100 2414.87 USD
+2.49
1.25B USD 2389.12 USD 2417.41 USD 1.25B USD
Dow Jones Composite Average DJA 12451.49 USD
+1.05
506.92M USD 12355.6 USD 12471.2 USD 506.92M USD
Dow Jones Industrial Average DJI 39069.11 USD
+1.18
330.54M USD 38802.1 USD 39149.6 USD 330.54M USD
Better Investing 100 BIXX 245.36 USD
0
Nasdaq US Price Setters Index NQPRCE 2550.63 USD
+1.42
2529.69 USD 2555.25 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1410.69 USD
<0.01
2100.38 AUD 1410.69 USD 2100.38 AUD 1410.69 USD
The Capital Strength Net Total NQCAPSTN 3545.28 USD
+1.15
3513.44 USD 3549.08 USD
Nasdaq US Low Volatility Divide LVDA 1164.3 USD
+0.27
1151.9 USD 1166.23 USD
NYSE ARCA PHARMACEUTICAL INDEX DRG 1019.18 USD
+1.43
NYSE ARCA MAJOR MARKET INDEX XMI 3552.04 USD
+1.19
NASDAQ US Broad Dividend Achiev DAA 3363.12 USD
+1.14
3336.37 USD 3367.96 USD
NYSE COMPOSITE (DJ) NYA 17565.07 USD
+1.05
Interbrand Best Global Brands I BRAND100 971.21 USD
0
971.21 USD 971.21 USD